IPWR — what changed in the latest 10-Q
A section-by-section comparison of IPWR's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-15
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +26 | −18 | ~8 | 7 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 0 |
| Legal proceedings | Text added/removed | +1 | −1 | 0 | 0 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Revenue. Revenue was $5,800 for the three months ended June 30, 2026, compared to $1,275 in the three months ended June 30, 2025. Revenue in the three months ended June 30, 2026 related to shipments under our purchase order from Stellantis. Revenue in the three months ended June 30, 2025 related to …
Cost of Revenue. Cost of revenue was $4,008 for the three months ended June 30, 2026, compared to $3,477 in the three months ended June 30, 2025. Cost of revenue in the three months ended June 30, 2026 related to the cost of products shipped under our purchase order from Stellantis. Cost of revenue …
Research and Development Expenses. Research and development expenses decreased by $469,885, or 25%, to $1,430,134 in the three months ended June 30, 2026 from $1,900,019 in the three months ended June 30, 2025. The decrease was due to lower semiconductor fabrication costs of $161,091, resulting from…
General and Administrative Expenses. General and administrative expenses increased by $760,733, or 85%, to $1,657,972 in the three months ended June 30, 2026 from $897,239 in the three months ended June 30, 2025. The increase was due to higher stock-based compensation expense of $420,255, of which $…
Text removed vs the prior filing · source: 10-Q · 2026-05-15
Revenue. Revenue was $0 for the three months ended March 31, 2026, compared to $12,003 for the three months ended March 31, 2025. For the three months ended March 31, 2025, our revenue included product sales and development revenue related to our first design win. We expect to recognize modest reven…
Cost of Revenue. Cost of revenue was $0 and $30,862 for the three months ended March 31, 2026 and 2025, respectively. For the three months ended March 31, 2025, our cost of revenue included cost of product sales and development expenses related to our first design win.
Gross Loss. We did not have a gross loss in the three months ended March 31, 2026. Our gross loss was $18,859 in the three months ended March 31, 2025 due to the higher costs associated with initial low volume production and costs exceeding revenue under the development agreement with our first desi…
Research and Development Expenses. Research and development expenses increased by $464,321, or 30%, to $2,032,313 in the three months ended March 31, 2026 from $1,567,992 in the three months ended March 31, 2025. The increase was due to higher stock-based compensation expense of $327,521, semiconduc…
General and Administrative Expenses. General and administrative expenses increased by $320,190, or 36%, to $1,220,011 in the three months ended March 31, 2026 from $899,821 in the three months ended March 31, 2025. The increase was due to higher stock-based compensation expense of $277,824, related …
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-13
We are subject to litigation from time to time. While we believe that any current or threatened legal proceedings are without merit and not material, there can be no assurance that such matters will not have a material adverse effect on our business, financial condition or results of operations in t…
Text removed vs the prior filing · source: 10-Q · 2026-05-15
We may be subject to litigation from time to time in the ordinary course of business. We are not currently party to any legal proceedings.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice